SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.86
−4.62%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-52.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | GERMAIN MARK · director | A-Award | 120,000,000 | $0.00 |
| Jun 18, 2026 | Reichman Amir · director, officer: Chief Executive Officer | A-Award | 400,000,000 | $0.00 |
| Sep 28, 2005 | BARRON PARTNERS LP · 10 percent owner | Sale | 547,323 | $0.46 |
| Sep 26, 2005 | BARRON PARTNERS LP · 10 percent owner | Sale | 5,000 | $0.50 |
| Sep 23, 2005 | BARRON PARTNERS LP · 10 percent owner | Sale | 5,000 | $0.51 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 18, 2026